News
on
|
Research Feature
Through an adaptive research trial, doctors and patients from 30 U.S. study locations are working together to study if five new medications can help patients with severe asthma by altering the underlying biology of this airway disease. As Erin Routh prepares to walk in winter weather, she does more than put on a jacket, hat, and gloves. The 46-year...
|
Media Availability
For Rare Disease Day 2022, NHLBI experts available to discuss rare heart, lung, and blood conditions
WHAT: To raise awareness about Rare Disease Day on February 28, researchers from the National Heart, Lung, and Blood Institute (NHLBI) are available to share updates about research designed to support people living with rare or uncommon heart, lung, and blood conditions. WHY: In the U.S., a condition is considered rare if it affects less than 200...
|
Media Availability
WHAT: Researchers have discovered new insights about lymphangioleiomyomatosis (LAM), a rare lung disease, which affects about 1 in 200,000 Americans and commonly features the growth of abnormal cells in different tissues and organs, including the lungs. As researchers studied LAM cells in the lab, they discovered a “mixed phenotype,” or differences...
|
News Release
Researchers have identified 57 genetic variations of a gene strongly associated with declines in blood oxygen levels during sleep. Low oxygen levels during sleep are a clinical indicator of the severity of sleep apnea, a disorder that increases the risk of heart disease, dementia, and death. The study, published today in the American Journal of...
|
Research Feature
Might pave the way for new and improved treatments for a wide variety of respiratory diseases Maps may be great tools for helping you find your way around unfamiliar places, but in the future, a new type of map well might help save your life. Welcome to the Molecular Atlas of Lung Development Program, or LungMAP, a historic effort to help...
|
Statement
On November 21, World COPD Day 2018, the National Institutes of Health unites with millions of people to renew our long-standing commitment to reducing the burden of chronic obstructive pulmonary disease ( COPD ), a serious and debilitating lung disease. A leading cause of death, COPD impacts an estimated 251 million people worldwide . While many...
|
News Release
The National Heart, Lung, and Blood Institute (NHLBI), along with federal and non-federal partners, today released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference...